Malaysiakini
ENBM中文TA
Sign In
Subscribe
  • LifetimeACTIVEINACTIVEEXPIRED
  • Registered on:Renews on:
    ACTIVEINACTIVEEXPIRED
  • Subscribe
  • Renew
  • Extend Subscription
  • Settings
  • Contact Support
  • Sign Out
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
Malaysiakini
Subscribe
  • Latest
  • Videos
  • Opinions
  • Yoursay
  • Featured
  • Kini News Lab
  • KiniGuide
  • Sustainability
  • Events
  • Collab Content
  • TopTech
  • Our Team
  • Privacy Policy
  • Terms of Service
  • Advertise with us
  • Careers
  • Email
  • WhatsApp
  • File a complaint
  • Address
ENBM中文TA

      ANNOUNCEMENT

      He was the sole candidate proposed for the post during a state committee meeting.

      He was the sole candidate proposed for the post during a state committee meeting.

      China steals march on West in developing nations' vaccine rollout
      Malaysiakini
      News
      China steals march on West in developing nations' vaccine rollout

      China steals march on West in developing nations' vaccine rollout

      ReutersPublished: Jan 15, 2021 10:45 AM

      China is stealing a march on Western drugmakers in the Covid-19 vaccine race in developing nations, with Indonesia and Turkey rolling out huge campaigns with a Chinese shot this week, Brazil due to follow soon, and even EU member Hungary signing up.

      Scientists in some Western countries say China has been too slow to publish trial data. Public reports so far about how well its vaccines work have been inconsistent, which the Chinese firms attribute to variations in methodology.

      Countries with hundreds of millions of people desperate for a vaccine think China’s shots are good enough.
      Explainer: What's behind varying efficacy data for Sinovac's vaccine?

      Explainer: What's behind varying efficacy data for Sinovac's vaccine?

      Covid-19 infection gives some immunity for at least five months but...

      Covid-19 infection gives some immunity for at least five months but...

      Deal's off if vaccine doesn’t pass muster, KJ assures amid doubts about Sinovac

      Deal's off if vaccine doesn’t pass muster, KJ assures amid doubts about Sinovac

      New Brazil data shows only 50.4% efficacy for China's CoronaVac vaccine

      New Brazil data shows only 50.4% efficacy for China's CoronaVac vaccine

      Indonesia launches vaccination drive as Covid-19 deaths hit record

      Indonesia launches vaccination drive as Covid-19 deaths hit record

      Sinovac vaccine cheaper as bottling to be done in M'sia - Khairy

      Sinovac vaccine cheaper as bottling to be done in M'sia - Khairy

      Phamaniaga all set to manufacture Sinovac Covid-19 vaccine

      Phamaniaga all set to manufacture Sinovac Covid-19 vaccine

      • comments0
      • facebook
      • whatsapp
      • x
      • comments0
      • facebook
      • whatsapp
      • x
      Related reports7

      Explainer: What's behind varying efficacy data for Sinovac's vaccine?

      14-01-2021

      Covid-19 infection gives some immunity for at least five months but...

      14-01-2021

      Deal's off if vaccine doesn’t pass muster, KJ assures amid doubts about Sinovac

      13-01-2021

      New Brazil data shows only 50.4% efficacy for China's CoronaVac vaccine

      13-01-2021

      Indonesia launches vaccination drive as Covid-19 deaths hit record

      13-01-2021

      Sinovac vaccine cheaper as bottling to be done in M'sia - Khairy

      12-01-2021

      Phamaniaga all set to manufacture Sinovac Covid-19 vaccine

      12-01-2021
      View Comments0

      Comment0

      By posting a comment, you agree to our Commenting Terms and Conditions as stipulated in full here.

      Do's and don'ts when posting comments in Malaysiakini

      TERMS & CONDITIONS

      Foul language, profanity, vulgarity, slanderous, personal attack, threatening, sexually-orientated comments or the use of any method of communication that may violate any law or create needless unpleasantness will not be tolerated. Antisocial behaviour such as "spamming" and "trolling" will be suspended. Violators run the risk of also being blocked permanently.

      REPORT VIOLATORS

      Please use the report feature that is available below each comment to flag offending comments for our moderators to take action. Do not take matters in your own hands to avoid unpleasant and unnecessary exchanges that may result in your own suspension or ban.

      Subscriber-only space:

      Are you a subscriber?

      Sign In

      Not yet a subscriber?

      Subscribe

      600 characters remaining
      mk-logo
      • whatsapp
      • telegram
      • youtube
      • facebook
      • x
      • instagram
      • tiktok
      • linkedin
      • About Us
      • Our Team
      • Privacy Policy
      • Terms of Service
      • Advertise with Us
      • Careers
      • Archive
      • Digital Network
      • KiniTV
      • FG Media
      • RSS Feeds
      • News
      • Opinion
      • Letters
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+6017-323 0707
      envelopesubscribe@malaysiakini.com
      • Advertising
      • advertise@malaysiakini.com
      • advertise@fgmedia.my
      Mkini Dotcom Sdn Bhd
      (199901014818 / 489718-U)No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor
      Contact Editorial
      envelopeeditor@malaysiakini.com
      Contact Subscription/Tech Support
      telephone+603-7770 0017
      envelopesubscribe@malaysiakini.com
      @Kini
      No. 9, Jalan 51/205A, Off Jalan Tandang, 46050 Petaling Jaya, Selangor